Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. M. Sargeant
OSU-HDAC42, a Histone Deacetylase Inhibitor, Blocks Prostate Tumor Progression in the Transgenic Adenocarcinoma of the Mouse Prostate Model
Cancer Research
Cancer Research
Oncology
Related publications
Lobe-Specific Carcinogenesis in the Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) Mouse Model
Suppression of Prostate Carcinogenesis by Dietary Supplementation of Celecoxib in Transgenic Adenocarcinoma of the Mouse Prostate Model
Cancer Research
Cancer Research
Oncology
Differential Requirement for Focal Adhesion Kinase Signaling in Cancer Progression in the Transgenic Adenocarcinoma of Mouse Prostate Model
Molecular Cancer Therapeutics
Cancer Research
Oncology
Dissociation of Epithelial and Neuroendocrine Carcinoma Lineages in the Transgenic Adenocarcinoma of Mouse Prostate Model of Prostate Cancer
American Journal of Pathology
Forensic Medicine
Pathology
2-Methoxyestradiol Inhibits Prostate Tumor Development in Transgenic Adenocarcinoma of Mouse Prostate: Role of Tumor Necrosis Factor- -Stimulated Gene 6
Clinical Cancer Research
Cancer Research
Oncology
The Histone Deacetylase Inhibitor Trichostatin a Blocks Progesterone Receptor-Mediated Transactivation of the Mouse Mammary Tumor Virus Promoterin Vivo
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Loss of Survivin in the Prostate Epithelium Impedes Carcinogenesis in a Mouse Model of Prostate Adenocarcinoma
PLoS ONE
Multidisciplinary
Retinoid Metabolism and ALDH1A2 (RALDH2) Expression Are Altered in the Transgenic Adenocarcinoma Mouse Prostate Model
Biochemical Pharmacology
Biochemistry
Pharmacology
Prostate Specific Expression of Maspin in a Transgenic Mouse Model: Implications in Prostate Carcinogenesis
